TITLE

DESIGNING AND SCREENING OF POTENT INHIBITOR AGAINST INHA REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS: A COMPUTATIONAL APPROACH

AUTHOR(S)
DEVI, URIKHIMBAM JOYLAXMI; CHETIA, PANKAJ; DEVI, THOKCKOM ANITA; CHOUDHURY, MANABENDRA DUTTA
PUB. DATE
April 2014
SOURCE
Asian Journal of Pharmaceutical & Clinical Research;2014, Vol. 7 Issue 2, p161
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: In this study, we attempt to design potent inhibitor specifically targeting the enoyl-acyl carrier protein reductase of Mycobacterium tuberculosis. Methods: In silico docking studies were performed using FlexX and Autodock Vina with ligand1 (library compound) and known inhibitors against enoyl acyl carrier protein reductase of Mycobacterium tuberculosis i.e., drug target. Ten proven inhibitors of InhA were selected from literature with their IC50 value and were correlated using EasyQSAR to generate QSAR model. Methods: In silico docking studies were performed using FlexX and Autodock Vina with ligand1 (library compound) and known inhibitors against enoyl acyl carrier protein reductase of Mycobacterium tuberculosis i.e., drug target. Ten proven inhibitors of InhA were selected from literature with their IC50 value and were correlated using EasyQSAR to generate QSAR model. Results and Discussions: By a two-step screening method, we identified a library compound expected to have high binding affinity to the enoyl acyl carrier protein reductase. Molecular docking with library compound showed good docking score better than known inhibitors. Drug like properties of these ligand1 were calculated by ADME/Tox calculations. The QSAR analysis of all standard compounds showed significant correlation with R square is 99.29 %. Conclusion: We therefore, propose that (2-((3,5-dimethoxyphenyl)(hydroxy)carbamoyl)-5-methylphenyl)(7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-3-yl)azinic acid is presenting better bioactivity against InhA target. Thus, this library compound as a potent InhA inhibitor and may be used in designing new anti-tubercular therapy.
ACCESSION #
96427830

 

Related Articles

  • Structure-based Design Of Benzophenone Inhibitors Targeting Enoyl-ACP Reductase Enzyme. Ramana, M. M. V.; Lokhande, R. S.; Joshi, Urmila J.; Gadre, Gayatri V.; Joshi, Akshada J. // International Journal of Pharmaceutical Sciences Review & Resear;May/Jun2014, Vol. 26 Issue 1, p134 

    Mycobacterium leprae is the causative agent of the disease, leprosy. As M. leprae develops resistance against most of the drugs, novel drug targets are required in order to design new drugs. The present study is aimed at finding the active site of the protein, which is used as a strategy in drug...

  • N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules. Rychtarčíková, Zuzana; Krátký, Martin; Gazvoda, Martin; Komlóová, Markéta; Polanc, Slovenko; Kočevar, Marijan; Stolaříková, Jiřina; Vinšová, Jarmila // Molecules;Apr2014, Vol. 19 Issue 4, p3851 

    This report presents a new modification of the isoniazid (INH) structure linked with different anilines via a carbonyl group obtained by two synthetic procedures and with N-substituted 5-(pyridine-4-yl)-1,3,4-oxadiazole-2-amines prepared by their cyclisation. All synthesised derivatives were...

  • Elucidating the structural basis of diphenyl ether derivatives as highly potent enoyl-ACP reductase inhibitors through molecular dynamics simulations and 3D-QSAR study. Kamsri, Pharit; Punkvang, Auradee; Saparpakorn, Patchareenart; Hannongbua, Supa; Irle, Stephan; Pungpo, Pornpan // Journal of Molecular Modeling;Jul2014, Vol. 20 Issue 7, p1 

    Diphenyl ether derivatives are good candidates for anti-tuberculosis agents that display a promising potency for inhibition of InhA, an essential enoyl-acyl carrier protein (ACP) reductase involved in fatty acid biosynthesis pathways in Mycobacterium tuberculosis. In this work, key structural...

  • Docking analysis of substituted pyrazoles as M. tuberculosis Enoyl ACP reductase inhibitors. Purnima, S.; Subashini, S.; Subhashini, N.; Solairaj, P. // Der Pharmacia Sinica;2013, Vol. 4 Issue 1, p88 

    Tuberculosis continues to be a major cause of morbidity and mortality all over the world. No new drug has been developed in the past 30 yr. Consequently, there is an urgent need to identify new drug targets in mycobacteria and eventually, develop new drugs. The enoyl acyl carrier protein...

  • Sequence-motif Detection of NAD(P)-binding Proteins: Discovery of a Unique Antibacterial Drug Target. Yun Hao Hua; Chih Yuan Wu; Sargsyan, Karen; Lim, Carmay // Scientific Reports;9/26/2014, p1 

    Many enzymes use nicotinamide adenine dinucleotide or nicotinamide adenine dinucleotide phosphate (NAD(P)) as essential coenzymes. These enzymes often do not share significant sequence identity and cannot be easily detected by sequence homology. Previously, we determined all distinct locally...

  • Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression. Grandgirard, Denis; Furi, Leonardo; Ciusa, Maria Laura; Baldassarri, Lucilla; Knight, Daniel R.; Morrissey, Ian; Largiadèr5, Carlo R.; Leib, Stephen L.; Oggioni, Marco R. // BMC Genomics;2015, Vol. 16 Issue 1, p1 

    Background: The enoyl-acyl carrier protein (ACP) reductase enzyme (FabI) is the target for a series of antimicrobial agents including novel compounds in clinical trial and the biocide triclosan. Mutations in fabI and heterodiploidy for fabI have been shown to confer resistance in S. aureus...

  • Synthesis, Docking, and Antibacterial Activity of Some Novel 4-Substituted s-triazino[1,2-a]benzimidazoles. Ammar, Yousry A.; El-Sehrawi, Hend M.; El-Zahabi, Heba S. A.; Shawer, Taghreed Z.; Ismail, Magda M. F. // Der Pharma Chemica;2012, Vol. 4 Issue 5, p2140 

    Two novel series of 2-amino-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazoles, and 2-amino-4,4-disubstituted/- spiro[1,3,5]triazino[1,2-a]benzimidazoles were synthesized and evaluated for their in vitro antibacterial activity against Staphylococcus aureus and Escherichia coli. Molecular modeling...

  • Isolation and characterization of an enoyl-acyl carrier protein reductase gene from microalga Isochrysis galbana. Zheng, Minggang; Liang, Kepeng; Wang, Bo; Sun, Xiuqin; Yue, Yanyan; Wan, Wenwen; Zheng, Li // Chinese Journal of Oceanology & Limnology;Mar2013, Vol. 31 Issue 2, p398 

    In most bacteria, plants and algae, fatty acid biosynthesis is catalyzed by a group of freely dissociable proteins known as the type II fatty acid synthase (FAS II) system. In the FAS II system, enoylacyl carrier protein reductase (ENR) acts as a determinant for completing the cycles of fatty...

  • Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors. da Silva Lima, Camilo Henrique; de Alencastro, Ricardo Bicca; Kaiser, Carlos Roland; de Souza, Marcus Vinícius Nora; Rodrigues, Carlos Rangel; Albuquerque, Magaly Girão // International Journal of Molecular Sciences;2015, Vol. 16 Issue 10, p23695 

    Molecular dynamics (MD) simulations of 12 aqueous systems of the NADH-dependent enoyl-ACP reductase from Mycobacterium tuberculosis (InhA) were carried out for up to 20-40 ns using the GROMACS 4.5 package. Simulations of the holoenzyme, holoenzyme-substrate, and 10 holoenzyme-inhibitor complexes...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics